We observed significantly higher mean levels of fasting and postprandial insulin (p < 0.01), fasting glucagon (p < 0.01), and postprandial glucagon (p < 0.01) in patients with T2DM as compared with controls (Table 1). The gene discussed is INS; the disease is type 2 diabetes mellitus.